Breast cancer screening and problem solving using mammography, ultrasound, and magnetic resonance imaging
- PMID: 21343800
- DOI: 10.1097/RUQ.0b013e31820e15ac
Breast cancer screening and problem solving using mammography, ultrasound, and magnetic resonance imaging
Abstract
Although mammography is the mainstay of early breast cancer detection, it has known limitations, particularly in women with dense breasts. As a result, additional imaging modalities, including ultrasound and contrast-enhanced magnetic resonance imaging, are also being used to supplement mammography in the early detection of occult breast cancer. This article reviews the indications and efficacy of mammography, ultrasound, and magnetic resonance imaging as both screening and diagnostic tools.
Similar articles
-
Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.J Am Coll Radiol. 2010 Jan;7(1):18-27. doi: 10.1016/j.jacr.2009.09.022. J Am Coll Radiol. 2010. PMID: 20129267
-
Role of imaging in diagnosis of carcinoma of breast.J Coll Physicians Surg Pak. 2005 Apr;15(4):238-41. J Coll Physicians Surg Pak. 2005. PMID: 15857599 Review.
-
Breast MR imaging: current indications and advanced imaging techniques.Radiol Clin North Am. 2010 Sep;48(5):1013-42. doi: 10.1016/j.rcl.2010.06.011. Radiol Clin North Am. 2010. PMID: 20868898 Review.
-
The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.Invest Radiol. 2009 Jul;44(7):412-21. doi: 10.1097/RLI.0b013e3181a53654. Invest Radiol. 2009. PMID: 19448554
-
[The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].Rofo. 2005 Jun;177(6):818-27. doi: 10.1055/s-2005-858203. Rofo. 2005. PMID: 15902631 Clinical Trial. German.
Cited by
-
The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer.Cancer Manag Res. 2019 Jan 17;11:865-876. doi: 10.2147/CMAR.S190591. eCollection 2019. Cancer Manag Res. 2019. PMID: 30697078 Free PMC article.
-
Quantitative assessment of tumor angiogenesis using real-time motion-compensated contrast-enhanced ultrasound imaging.Angiogenesis. 2012 Sep;15(3):433-42. doi: 10.1007/s10456-012-9271-3. Epub 2012 Apr 26. Angiogenesis. 2012. PMID: 22535383 Free PMC article.
-
Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations.J Med Screen. 2016 Mar;23(1):24-30. doi: 10.1177/0969141315591616. Epub 2015 Jun 15. J Med Screen. 2016. PMID: 26078275 Free PMC article.
-
AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.PLoS One. 2015 Apr 15;10(4):e0122106. doi: 10.1371/journal.pone.0122106. eCollection 2015. PLoS One. 2015. PMID: 25875093 Free PMC article.
-
Semi-anthropomorphic photoacoustic breast phantom.Biomed Opt Express. 2019 Oct 29;10(11):5921-5939. doi: 10.1364/BOE.10.005921. eCollection 2019 Nov 1. Biomed Opt Express. 2019. PMID: 31799055 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials